HomePHGUF • OTCMKTS
Pharming Group N.V.
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 92.70M | 14.14% |
Operating expense | 73.80M | -17.44% |
Net income | 3.70M | 218.48% |
Net profit margin | 3.99 | 203.64% |
Earnings per share | 0.01 | 225.00% |
EBITDA | 15.50M | 300.27% |
Effective tax rate | 43.94% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 167.89M | -21.33% |
Total assets | 400.79M | -13.41% |
Total liabilities | 178.93M | -26.69% |
Total equity | 221.86M | — |
Shares outstanding | 740.00M | — |
Price to book | 3.00 | — |
Return on assets | 4.72% | — |
Return on capital | 5.68% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 3.70M | 218.48% |
Cash from operations | 9.33M | -19.38% |
Cash from investing | -9.79M | -150.51% |
Cash from financing | -2.20M | -116.08% |
Net change in cash | -5.72M | -180.67% |
Free cash flow | 4.47M | 233.23% |
Previous close
$0.90
Year range
$0.75 - $1.07
Market cap
564.41M EUR
Avg Volume
5.93K
P/E ratio
-
Dividend yield
-
Primary exchange
AMS
About
Founded
1988
Website
Employees
382